ACER - オペクサ・セラピュ―ティクス (Acer Therapeutics Inc.)

ACERのニュース

   Comparing Acer Therapeutics (NASDAQ:ACER) and CV Sciences (OTCMKTS:CVSI)  2021/12/12 06:12:42 Dakota Financial News
Acer Therapeutics (NASDAQ:ACER) and CV Sciences (OTCMKTS:CVSI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk. Profitability This table compares Acer Therapeutics and CV Sciences net margins, return on equity and []
   Acer Therapeutics wins FDA nod for hot flashes trial  2021/12/09 14:21:04 Seeking Alpha
   Acer Therapeutics Announces ACER-801 IND Clearance for the Treatment of Induced Vasomotor Symptoms  2021/12/09 13:30:00 Intrado Digital Media
Phase 2a trial initiation expected in Q1 2022
   Acer Therapeutics (NASDAQ:ACER) Stock Rating Upgraded by Zacks Investment Research  2021/12/09 08:36:41 Transcript Daily
Acer Therapeutics (NASDAQ:ACER) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The companys product pipeline consists of []
   -$0.24 Earnings Per Share Expected for Acer Therapeutics Inc. (NASDAQ:ACER) This Quarter  2021/12/05 14:46:42 Dakota Financial News
Equities analysts expect that Acer Therapeutics Inc. (NASDAQ:ACER) will announce earnings of ($0.24) per share for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Acer Therapeutics earnings. The lowest EPS estimate is ($0.25) and the highest is ($0.22). Acer Therapeutics posted earnings of ($0.50) per share during the same []
   Black Friday Alienware Deals (2021): Top Early Alienware x15 Laptop, 1080p Monitor & More Savings Identified by Consumer Walk  2021/11/08 09:40:00 Kwhen Finance
   Black Friday Gaming PC Deals (2021): Early NZXT, CyberPowerPC & More Gaming Computer Savings Reviewed by Consumer Walk  2021/11/07 12:30:00 Kwhen Finance
   Black Friday Gaming Monitor Deals 2021: Early Curved, 27 Inch, 4K & More Sales Published by Saver Trends  2021/11/07 11:50:00 Kwhen Finance
   Best Black Friday Gaming Laptop Deals 2021: Best Early ASUS, HP, Acer & More Laptop Savings Summarized by Deal Tomato  2021/11/07 10:40:00 Kwhen Finance
   Chromebook Black Friday Deals (2021): Early Acer, Lenovo, ASUS & More Sales Ranked by Retail Fuse  2021/11/06 14:05:00 Kwhen Finance
   Here is What Hedge Funds Think About Acer Therapeutics Inc. (ACER)  2021/06/13 18:11:56 Insider Monkey
   Acer Therapeutics (ACER) Receives a Hold from Needham  2021/06/11 19:15:07 Smarter Analyst
Needham analyst Serge Belanger maintained a Hold rating on Acer Therapeutics (ACER) today. The companys shares closed last Friday at $3. The post Acer Therapeutics (ACER) Receives a Hold from Needham appeared first on Smarter Analyst .
   Acer Therapeutics plans clinical trial of Edsivo in connective-tissue disorder  2021/06/10 13:14:21 Seeking Alpha
   Acer Therapeutics Plans Clinical Trial for EDSIVO (celiprolol) Following Type B FDA Meeting  2021/06/10 12:30:00 Wallstreet:Online
Phase 3, randomized, double-blind, placebo-controlled, decentralized clinical trial estimated to take approximately 3.5 years to complete once fully enrolled FDA indicates agreement with submission of proposed protocol under a Special Protocol Assessment (SPA) with possible breakthrough designation NEWTON, Mass., June 10, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical
   Acer Therapeutics plans NDA submission for ACER-001 in Q3 2021  2021/05/25 12:48:36 Seeking Alpha

calendar